| Financial Year |
March 31 2023 |
| Monetary Funds |
1,216,372,320.46 |
| Held-for-trading Financial Assets |
791,186,335.38 |
| Notes Receivable |
218,139,787.17 |
| Accounts Receivable |
1,437,465,248.77 |
| Advances to Suppliers |
80,797,227.92 |
| Other Receivables |
36,627,287.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,155,235,651.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,201,953.81 |
| Other Current Assets |
55,052,481.99 |
| Total Current Assets |
5,450,827,913.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,101,999.81 |
| Long-term Equity Investment |
51,106,228.35 |
| Investment Properties |
-- |
| Fixed Assetes |
790,882,365.53 |
| Under-construction Projects |
137,958,216.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
537,768,307.71 |
| R&D expenses |
121,166,352.60 |
| Goodwill |
1,485,681,429.88 |
| Long-Term Deferred and Prepaid Expenses |
46,976,657.74 |
| Deferred Income Tax Assets |
195,742,741.56 |
| Other Non-Current Assets |
28,523,610.14 |
| Sub-Total of Non-Current Assets |
3,872,460,105.52 |
| Total Assets |
9,323,288,019.19 |
| Short-Term Loans |
1,103,008,781.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
608,875,972.93 |
| Accounts Payable |
784,633,079.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
92,400,093.00 |
| Taxes Payable |
79,208,788.09 |
| Interest Payable |
-- |
| Dividend Payable |
980,000.00 |
| Other payables |
172,234,605.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
600,867,132.68 |
| Other Current Liabilities |
55,437,478.69 |
| Sub-Total of Current Liabilities |
3,741,919,888.50 |
| Long-term Loans |
2,030,969,125.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
34,485,170.27 |
| Deferred Income Tax Liabilities |
83,804,533.80 |
| Other Non-Current Liabilities |
9,103,770.22 |
| Sub-Total of Non-Current Liabilities |
2,464,685,777.58 |
| Total Liabilities |
6,206,605,666.08 |
| Paid-In Capital(Or Share Stock) |
869,115,493.00 |
| Capital Surplus |
1,221,984,324.39 |
| Surplus Reserve |
69,439,751.49 |
| LESS:Treasury Stock |
69,305,077.10 |
| Undistributed Profits |
668,245,211.44 |
| Minority Stockholder's Interest |
287,600,130.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,829,082,222.14 |
| Owner's Equity（Stockholder's Equity） |
3,116,682,353.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,323,288,019.19 |
